文献速递骨肿瘤

胫骨内注射导致骨肉瘤细胞直接肺种植而非自发性转移模型:小鼠骨肉瘤模型研究

Intratibial Injection Causes Direct Pulmonary Seeding of Osteosarcoma Cells and Is Not a Spontaneous Model of Metastasis: A Mouse Osteosarcoma Model.
PubMed 文献 · Clin Orthop Relat Res · 2018-01-01

该研究评估常用小鼠骨肉瘤模型K7M2胫骨内注射后肺转移发生机制。最大无渗漏注射体积为10 μL,注射后4周93%小鼠成瘤且100%可检出肺转移,最早1周即可检出。注射后30分钟截肢不影响4周时肺转移负荷,表明肺转移为注射后立即种植而非原发瘤自发转移。

要点

  • K7M2细胞胫骨内注射最大无渗漏体积为10 μL。
  • 注射后4周93%小鼠形成髓内原发瘤,100%可检出肺转移。
  • 注射后30分钟截肢不影响4周肺转移负荷,转移为直接种植。

核心结论

  • 胫骨内注射K7M2骨肉瘤细胞后转移部位立即发生种植,不依赖于原发瘤,因此该模型不是自发性转移模型。
  • 该模型不应用于研究转移级联的早期环节,而应作为转移的实验模型使用。

研究设计与样本

  • 将小鼠骨肉瘤细胞系K7M2注射入小鼠胫骨。
  • 用伊文思蓝染料确定最大无渗漏注射体积(n=8只小鼠)。
  • 注射后4周测定原发瘤形成率和转移效率(n=30只小鼠)。
  • 注射后1、2、3、4周系列安乐死观察转移发展动力学(n=24只,每组5-6只)。
  • 注射后30分钟、4小时或24小时行截肢术以检验原发瘤对后续转移的贡献(n=21只,每组5-6只),4周后计算转移负荷并与未截肢对照比较。

主要发现

  • 最大无渗漏细胞悬液注射体积为10 μL。
  • 胫骨内注射肿瘤细胞后4周93%小鼠形成髓内肿瘤,这些小鼠中100%早在注射后1周即可检出肺转移。
  • 转移负荷随时间增加:第1周0.88%±0.58,第2周6.6%±5.3,第3周16.1%±12.5,第4周40.3%±14.83;第1周至第4周平均差值为-39.38(p<0.001;95%CI,-57.39至-21.37)。
  • 转移灶平均数量从第1周至第4周未增加(36.4±33.6 vs 49.3±26.3,p=0.18)。
  • 注射后30分钟、4小时和24小时截肢未影响4周时肺转移负荷,注射后30分钟即截肢的转移负荷与荷瘤对照相当(48.9%±6.1% vs 40.9%±15.3%,平均差值7.96,p=0.819;95%CI,-33.9至18.0)。

临床怎么用

  • 作者认为该模型不应用于研究转移级联的早期环节,而应作为转移的实验模型使用。
  • 作者认为加深对这一常用模型的理解将有助于正确解读现有数据,并为未来探索骨肉瘤转移生物学的研究设计提供信息。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although metastasis is the major cause of mortality in patients with osteosarcoma, little is known about how micrometastases progress to gross metastatic disease. Clinically relevant animal models are necessary to facilitate development of new therapies to target indolent pulmonary metastases. Intratibial injection of human and murine osteosarcoma cell lines have been described as orthotopic models that develop spontaneous pulmonary metastasis over time. However, there is variability in reported injection techniques and metastatic efficiency. QUESTIONS/PURPOSES: We aimed to characterize a widely used murine model of metastatic osteosarcoma, determine whether it is appropriate to study spontaneous pulmonary metastasis by establishing a reliable volume for intratibial injection, determine the incidence of primary tumor and metastatic formation, determine the kinetics of pulmonary metastatic seeding and outgrowth, and the contribution of the primary tumor to subsequent development of metastasis. METHODS: The metastatic mouse osteosarcoma cell line K7M2 was injected into the tibia of mice. The maximum volume that could be injected without leakage was determined using Evan's blue dye (n = 8 mice). Primary tumor formation and metastatic efficiency were determined by measuring the incidence of primary tumor and metastatic formation 4 weeks after intratibial injection (n = 30). The kinetics of metastatic development were determined by performing serial euthanasia at 1, 2, 3, and 4 weeks after injection (n = 24; five to six mice per group). Number of metastatic foci/histologic lung section and metastatic burden/lung section (average surface area of metastatic lesions divided by the total surface area of the lung) was calculated in a blinded fashion. To test the contribution of the primary tumor to subsequent metastases, amputations were performed 30 minutes, 4 hours, or 24 hours after injection (n = 21; five to six mice per group). Mice were euthanized after 4 weeks and metastatic burden calculated as described previously, comparing mice that had undergone amputation with control, nonamputated mice. Differences between groups were calculated using Kruskal-Wallis and one-way analysis of variance. RESULTS: The maximum volume of cell suspension that could be injected without leakage was 10 μL. Intratibial injection of tumor cells led to intramedullary tumor formation in 93% of mice by 4 weeks and resulted in detectable pulmonary metastases in 100% of these mice as early as 1 week post-injection. Metastatic burden increased over time (0.88% ± 0.58, week 1; 6.6% ± 5.3, week 2; 16.1% ± 12.5, week 3; and 40.3% ± 14.83, week 4) with a mean difference from week 1 to week 4 of -39.38 (p < 0.001; 95% confidence interval [CI], -57.39 to -21.37), showing pulmonary metastatic growth over time. In contrast, the mean number of metastatic foci did not increase from week 1 to week 4 (36.4 ± 33.6 versus 49.3 ± 26.3, p = 0.18). Amputation of the injected limb at 30 minutes, 4 hours, and 24 hours after injection did not affect pulmonary metastatic burden at 4 weeks, with amputation as early as 30 minutes post-injection resulting in a metastatic burden equivalent to tumor-bearing controls (48.9% ± 6.1% versus 40.9% ± 15.3%, mean difference 7.96, p = 0.819; 95% CI, -33.9 to 18.0). CONCLUSIONS: There is immediate seeding of the metastatic site after intratibial injection of the K7M2 osteosarcoma cell line, independent of a primary tumor. This is therefore not a model of spontaneous metastasis. CLINICAL RELEVANCE: This model should not be used to study the early components of the metastatic cascade, but rather used as an experimental model of metastasis. Improved understanding of this commonly used model will allow for proper interpretation of existing data and inform the design of future studies exploring the biology of metastasis in osteosarcoma.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Maloney C, Edelman MC, Kallis MP, et al. Intratibial Injection Causes Direct Pulmonary Seeding of Osteosarcoma Cells and Is Not a Spontaneous Model of Metastasis: A Mouse Osteosarcoma Model. Clin Orthop Relat Res. 2018. PMID: 29601385. doi:10.1007/s11999.0000000000000291

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。